Real-time tissue oxygen saturation measurement technology improving surgical outcomes. The company is dedicated to providing technology that helps improve patient outcomes. They develop and market clinically validated, FDA-cleared products adopted as standard care in leading hospitals. Their products measure tissue oxygen saturation in real-time, offering clinicians access to tissue oxygenation data. They focus on innovation, customer service, and strategic product development. The company operates in the Disease Self Management sector with additional focus on Healthcare IT and Cardiac and Vascular Disorders. Its business model centers on Remote Patient Monitoring. Founded in 1999, headquartered in Fremont, United States. The company has raised $31.6M at the Series E stage. Backed by investors including Channel Medical Partners, Canadian Medical, Morningside, Vivo Capital, Trident Capital and others.
Vioptix
Series EReal-time tissue oxygen saturation measurement technology improving surgical outcomes. The company is dedicated to providing technology that helps improve patient outcomes. They develop and market clinically validated, FDA-cleared products adopted as standard care in leading hospitals. Their products measure tissue oxygen saturation in real-time, offering clinicians access to tissue oxygenation data. They focus on…
About
Business model
Wearable Technology > Health and Wellness Devices > Remote Patient Monitoring,
Disease Self Management > Geriatrics > Monitoring > Device,
Healthcare IT > Value Based Care > Care Coordination > Care Planning & Management > Elderly > Care Home Resident Monitoring > Remote Monitoring > Sensors,
Cardiac and Vascular Disorders > Medical Devices > Monitoring Devices > Tissue Oxygenation
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.